Efficacy and Tolerability of Hydroxychloroquine in Adult Patients With COVID-19

NACompletedINTERVENTIONAL
Enrollment

33

Participants

Timeline

Start Date

April 1, 2020

Primary Completion Date

May 31, 2020

Study Completion Date

May 31, 2020

Conditions
Coronavirus Infection
Interventions
DRUG

Hydroxychloroquine Sulfate 200 MG [Plaquenil]

Hydroxychloroquine Sulfate is 400 mg bid on Day 1 and 200 mg bid for 6 days on Day 2-7.

Trial Locations (1)

320

Taoyuan General Hospital, Ministry of Health and Welfare, Taoyuan

All Listed Sponsors
collaborator

Center for Drug Evaluation, Taiwan

UNKNOWN

collaborator

Centers for Disease Control, Taiwan

OTHER_GOV

collaborator

Taiwan Food and Drug Administration

UNKNOWN

collaborator

National Health Research Institutes, Taiwan

OTHER

lead

Taoyuan General Hospital

OTHER_GOV

NCT04384380 - Efficacy and Tolerability of Hydroxychloroquine in Adult Patients With COVID-19 | Biotech Hunter | Biotech Hunter